PATH Launches New Vaccine Research Program for Pandemic Influenza

SEATTLE and WASHINGTON, D.C. — With global health leaders increasingly concerned about the near-term possibility of an influenza pandemic, PATH today announced a new program to support rapid development of vaccines to protect against a future outbreak that could swiftly spread around the globe in today’s highly mobile and connected world.

To read the full press release, visit the PATH Web site.